NBY Financial Facts
Other income (expense), net: -52KGeneral and administrative: 2.22M
See Full Income Statement
Deferred rent: 248K
TOTAL ASSETS: 15.14M
See Full Balance Sheet
NovaBay Pharma (NBY) Earnings
|
Expand Research on NBY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -59.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/24  |
Q423 | -$1.37 | -$1.22 | -$0.15 | $2.4M | $3.15M | N/A |  | | Details | |
| 11/9/23 | Q323 | -$0.37 | -$0.41 | +$0.04 | $3.27M | $3.54M | N/A | | | Details | |
| 11/14/22 | Q322 | -$0.10 | -$0.03 | -$0.07 | $3.83M | $3.75M | N/A | | | Details | |
| 8/11/22 | Q222 | -$0.04 | -$0.04 | $0.00 | $2.13M | $3.5M | N/A | | | Details | |
| 5/11/23 | Q122 | -$0.85 | -$0.53 | -$0.32 | $3.12M | $5.45M | N/A | | | Details | |
| 3/29/22 |  |
Q421 | -$0.02 | -$0.05 | +$0.03 | $2.6M | $3.34M | N/A | | | Details |
| 8/12/21 | |
Q221 | -$0.04 | -$0.04 | $0.00 | $2.1M | $2.01M | N/A | | | Details |
| 5/6/21 |
|
Q121 | N/A | -$0.04 | N/A | N/A | $2.34M | N/A | N/A | N/A |
